Why is biomarker testing so important in lung cancer care? This podcast episode is dedicated to Lorraine Tyler, an advocate and woman with lung cancer, who sadly passed away after it was recorded. Lorraine and Mark Brooke, CEO of Lung Foundation Australia, share touching personal insights and explore the need for people to know why, how and when to talk to their doctor about testing. On behalf of Roche, we would like to celebrate Lorraine, who worked so tirelessly to help others.

Why is biomarker testing so important in lung cancer care? This podcast episode is dedicated to Lorraine Tyler, an advocate and woman with lung cancer, who sadly passed away after it was recorded. Lorraine and Mark Brooke, CEO of Lung Foundation Australia, share touching personal insights and explore the need for people to know why, how and when to talk to their doctor about testing. On behalf of Roche, we would like to celebrate Lorraine, who worked so tirelessly to help others.

Why is biomarker testing so important in lung cancer care? This podcast episode is dedicated to Lorraine Tyler, an advocate and woman with lung cancer, who sadly passed away after it was recorded. Lorraine and Mark Brooke, CEO of Lung Foundation Australia, share touching personal insights and explore the need for people to know why, how and when to talk to their doctor about testing. On behalf of Roche, we would like to celebrate Lorraine, who worked so tirelessly to help others.&nbsp;

Biomarker testing in lung cancer

Redefining Lung Cancer Together is a podcast brought to you by Roche, aimed at supporting people with lung cancer on their patient journey. Hit the listen button if you're interested in learning more!

Share Redefining Lung Cancer Together

Sign up to save your podcasts

Redefining Lung Cancer Together

Redefining Lung Cancer Together episodes

About Redefining Lung Cancer Together